Research and Development
CreaGens discovery research services currently supports several disease areas including metabolic syndrome, specifically Type II diabetes, infection, inflammation, CNS, neurodegeneration and oncology. Current programs encompass these important target classes that represent 70% of the drugs currently on the market.

CreaGen Team is constantly involved in developing novel preclinical candidates for our partners in the following areas:

Synthetic small molecules and
Natural Products

For more information
Please contact our R & D Coordinator
  CreaGen Inc. makes into the 2018 list of major players in CRO industry   more...
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.